Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms iPSCs Orig3n, iPSderived cell therapy Orig3n |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Seaport Diagnostics, Inc.Startup |
Active Organization Seaport Diagnostics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Preclinical | US | Seaport Diagnostics, Inc.Startup | - |